Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 271

1.

Radiation Therapy for Solitary Plasmacytoma and Multiple Myeloma: Guidelines From the International Lymphoma Radiation Oncology Group.

Tsang RW, Campbell BA, Goda JS, Kelsey CR, Kirova YM, Parikh RR, Ng AK, Ricardi U, Suh CO, Mauch PM, Specht L, Yahalom J.

Int J Radiat Oncol Biol Phys. 2018 Jul 15;101(4):794-808. doi: 10.1016/j.ijrobp.2018.05.009. Epub 2018 Jun 20. Review. Erratum in: Int J Radiat Oncol Biol Phys. 2018 Dec 1;102(5):1602.

PMID:
29976492
2.

The Role of Radiation Therapy in Patients With Relapsed or Refractory Hodgkin Lymphoma: Guidelines From the International Lymphoma Radiation Oncology Group.

Constine LS, Yahalom J, Ng AK, Hodgson DC, Wirth A, Milgrom SA, Mikhaeel NG, Eich HT, Illidge T, Ricardi U, Dieckmann K, Moskowitz CH, Advani R, Mauch PM, Specht L, Hoppe RT.

Int J Radiat Oncol Biol Phys. 2018 Apr 1;100(5):1100-1118. doi: 10.1016/j.ijrobp.2018.01.011. Epub 2018 Jan 9. Review.

3.

Role of Radiation Therapy in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Guidelines from the International Lymphoma Radiation Oncology Group.

Ng AK, Yahalom J, Goda JS, Constine LS, Pinnix CC, Kelsey CR, Hoppe B, Oguchi M, Suh CO, Wirth A, Qi S, Davies A, Moskowitz CH, Laskar S, Li Y, Mauch PM, Specht L, Illidge T.

Int J Radiat Oncol Biol Phys. 2018 Mar 1;100(3):652-669. doi: 10.1016/j.ijrobp.2017.12.005. Review.

PMID:
29413279
4.

Management and outcomes of women diagnosed with primary breast lymphoma: a multi-institution experience.

Lalani N, Winkfield KM, Soto DE, Yeap BY, Ng AK, Mauch PM, Jimenez RB.

Breast Cancer Res Treat. 2018 May;169(1):197-202. doi: 10.1007/s10549-018-4671-8. Epub 2018 Jan 22.

PMID:
29356916
5.

Reduced Mortality Risk in the Recent Era in Early-Stage Hodgkin Lymphoma Patients Treated With Radiation Therapy With or Without Chemotherapy.

Patel CG, Michaelson E, Chen YH, Silver B, Marcus KJ, Stevenson MA, Mauch PM, Ng AK.

Int J Radiat Oncol Biol Phys. 2018 Feb 1;100(2):498-506. doi: 10.1016/j.ijrobp.2017.09.048. Epub 2017 Oct 5.

PMID:
29153331
6.

Improving health in at-risk youth through Photovoice.

Bashore L, Alexander GK, Jackson DL, Mauch P.

J Child Health Care. 2017 Dec;21(4):463-475. doi: 10.1177/1367493517734391. Epub 2017 Oct 2.

PMID:
29110527
7.

Clinical outcome of patients with early stage favorable Hodgkin lymphoma treated with ABVD × two cycles followed by FDG-PET/CT restaging and 20 Gy of involved-site radiotherapy.

Kamran SC, Jacene HA, Chen YH, Mauch PM, Ng AK.

Leuk Lymphoma. 2018 Jun;59(6):1384-1390. doi: 10.1080/10428194.2017.1376745. Epub 2017 Sep 22.

PMID:
28937297
8.

Early-stage mantle cell lymphoma: a retrospective analysis from the International Lymphoma Radiation Oncology Group (ILROG).

Dabaja BS, Zelenetz AD, Ng AK, Tsang RW, Qi S, Allen PK, Hodgson D, Ricardi U, Hoppe RT, Advani R, Mauch PM, Constine LS, Specht L, Li Y, Terezakis SA, Wirth A, Reinartz G, Eich HT, Aleman BMP, Barr P, Yahalom J.

Ann Oncol. 2017 Sep 1;28(9):2185-2190. doi: 10.1093/annonc/mdx334.

PMID:
28911068
9.

Hodgkin Lymphoma Version 1.2017, NCCN Clinical Practice Guidelines in Oncology.

Hoppe RT, Advani RH, Ai WZ, Ambinder RF, Aoun P, Bello CM, Benitez CM, Bernat K, Bierman PJ, Blum KA, Chen R, Dabaja B, Forero A, Gordon LI, Hernandez-Ilizaliturri FJ, Hochberg EP, Huang J, Johnston PB, Kaminski MS, Kenkre VP, Khan N, Maloney DG, Mauch PM, Metzger M, Moore JO, Morgan D, Moskowitz CH, Mulroney C, Poppe M, Rabinovitch R, Seropian S, Smith M, Winter JN, Yahalom J, Burns J, Ogba N, Sundar H.

J Natl Compr Canc Netw. 2017 May;15(5):608-638.

PMID:
28476741
10.

Hodgkin lymphoma, version 2.2015.

Hoppe RT, Advani RH, Ai WZ, Ambinder RF, Aoun P, Bello CM, Benitez CM, Bierman PJ, Blum KA, Chen R, Dabaja B, Forero A, Gordon LI, Hernandez-Ilizaliturri FJ, Hochberg EP, Huang J, Johnston PB, Khan N, Maloney DG, Mauch PM, Metzger M, Moore JO, Morgan D, Moskowitz CH, Mulroney C, Poppe M, Rabinovitch R, Seropian S, Tsien C, Winter JN, Yahalom J, Burns JL, Sundar H; National comprehensive cancer network.

J Natl Compr Canc Netw. 2015 May;13(5):554-86.

11.

Low-dose chest computed tomography for lung cancer screening among Hodgkin lymphoma survivors: a cost-effectiveness analysis.

Wattson DA, Hunink MG, DiPiro PJ, Das P, Hodgson DC, Mauch PM, Ng AK.

Int J Radiat Oncol Biol Phys. 2014 Oct 1;90(2):344-53. doi: 10.1016/j.ijrobp.2014.06.013. Epub 2014 Aug 4.

PMID:
25104066
12.

Four-dimensional versus 3-dimensional computed tomographic planning for gastric mucosa associated lymphoid tissue lymphoma.

Jang JW, Brown JG, Mauch PM, Ng AK.

Pract Radiat Oncol. 2013 Apr-Jun;3(2):124-9. doi: 10.1016/j.prro.2012.05.004. Epub 2012 Jun 12.

PMID:
24674315
13.

Modern radiation therapy for Hodgkin lymphoma: field and dose guidelines from the international lymphoma radiation oncology group (ILROG).

Specht L, Yahalom J, Illidge T, Berthelsen AK, Constine LS, Eich HT, Girinsky T, Hoppe RT, Mauch P, Mikhaeel NG, Ng A; ILROG.

Int J Radiat Oncol Biol Phys. 2014 Jul 15;89(4):854-62. doi: 10.1016/j.ijrobp.2013.05.005. Epub 2013 Jun 18.

PMID:
23790512
14.

Prospective study of the efficacy of breast magnetic resonance imaging and mammographic screening in survivors of Hodgkin lymphoma.

Ng AK, Garber JE, Diller LR, Birdwell RL, Feng Y, Neuberg DS, Silver B, Fisher DC, Marcus KJ, Mauch PM.

J Clin Oncol. 2013 Jun 20;31(18):2282-8. doi: 10.1200/JCO.2012.46.5732. Epub 2013 Apr 22.

PMID:
23610104
15.

Low-dose involved-field radiation in the treatment of non-hodgkin lymphoma: predictors of response and treatment failure.

Russo AL, Chen YH, Martin NE, Vinjamoori A, Luthy SK, Freedman A, Michaelson EM, Silver B, Mauch PM, Ng AK.

Int J Radiat Oncol Biol Phys. 2013 May 1;86(1):121-7. doi: 10.1016/j.ijrobp.2012.12.024. Epub 2013 Feb 12.

PMID:
23414765
16.

Radiotherapy in the management of localized primary cutaneous B-cell lymphoma.

Pashtan I, Mauch PM, Chen YH, Dorfman DM, Silver B, Ng AK.

Leuk Lymphoma. 2013 Apr;54(4):726-30. doi: 10.3109/10428194.2012.723707. Epub 2012 Sep 14.

PMID:
22916994
17.

Influence of new late effects on quality of life over time in Hodgkin lymphoma Survivors: a longitudinal survey study.

Khimani N, Chen YH, Mauch PM, Recklitis C, Diller L, Silver B, Ng AK.

Ann Oncol. 2013 Jan;24(1):226-30. doi: 10.1093/annonc/mds243. Epub 2012 Aug 8.

PMID:
22875834
18.

Primary bone lymphoma involving bilateral tibia.

Giardino AA, Shinagare AB, Shinagare SA, Dewar R, Weckstein D, Mauch P, Ramaiya NH, Freedman AS.

Am J Hematol. 2012 Sep;87(9):924-5. doi: 10.1002/ajh.23245. Epub 2012 May 28. No abstract available.

19.

Combined modality treatment for PET-positive non-Hodgkin lymphoma: favorable outcomes of combined modality treatment for patients with non-Hodgkin lymphoma and positive interim or postchemotherapy FDG-PET.

Halasz LM, Jacene HA, Catalano PJ, Van den Abbeele AD, Lacasce A, Mauch PM, Ng AK.

Int J Radiat Oncol Biol Phys. 2012 Aug 1;83(5):e647-54. doi: 10.1016/j.ijrobp.2012.01.060. Epub 2012 May 18.

PMID:
22607911
20.

Hodgkin lymphoma, version 2.2012 featured updates to the NCCN guidelines.

Hoppe RT, Advani RH, Ai WZ, Ambinder RF, Aoun P, Bello CM, Bierman PJ, Blum KA, Chen R, Dabaja B, Duron Y, Forero A, Gordon LI, Hernandez-Ilizaliturri FJ, Hochberg EP, Maloney DG, Mansur D, Mauch PM, Metzger M, Moore JO, Morgan D, Moskowitz CH, Poppe M, Pro B, Winter JN, Yahalom J, Sundar H; National Comprehensive Cancer Network.

J Natl Compr Canc Netw. 2012 May;10(5):589-97.

PMID:
22570290
21.

Employment and insurance in survivors of Hodgkin lymphoma and their siblings: a questionnaire study.

Chen AB, Feng Y, Neuberg D, Recklitis C, Diller LR, Mauch PN, Ng AK.

Leuk Lymphoma. 2012 Aug;53(8):1474-80. doi: 10.3109/10428194.2012.660629. Epub 2012 Mar 1.

PMID:
22280535
22.

Posttraumatic stress disorder (PTSD) in survivors of Hodgkin's lymphoma: prevalence of PTSD and partial PTSD compared with sibling controls.

Varela VS, Ng A, Mauch P, Recklitis CJ.

Psychooncology. 2013 Feb;22(2):434-40. doi: 10.1002/pon.2109. Epub 2011 Dec 8.

23.

Lung malignancies after Hodgkin lymphoma: disease characteristics, detection methods and clinical outcome.

Schoenfeld JD, Mauch PM, Das P, Silver B, Marcus KJ, Stevenson MA, Ng AK.

Ann Oncol. 2012 Jul;23(7):1813-8. doi: 10.1093/annonc/mdr551. Epub 2011 Nov 21.

PMID:
22104573
24.

Predictive factors for radiation pneumonitis in Hodgkin lymphoma patients receiving combined-modality therapy.

Fox AM, Dosoretz AP, Mauch PM, Chen YH, Fisher DC, LaCasce AS, Freedman AS, Silver B, Ng AK.

Int J Radiat Oncol Biol Phys. 2012 May 1;83(1):277-83. doi: 10.1016/j.ijrobp.2011.05.078. Epub 2011 Oct 20.

PMID:
22019238
25.

Hodgkin lymphoma.

Hoppe RT, Advani RH, Ai WZ, Ambinder RF, Bello CM, Bierman PJ, Blum KA, Dabaja B, Duron Y, Forero A, Gordon LI, Hernandez-Ilizaliturri FJ, Hochberg EP, Maloney DG, Mansur D, Mauch PM, Metzger M, Moore JO, Morgan D, Moskowitz CH, Poppe M, Pro B, Weiss L, Winter JN, Yahalom J; NCCN Hodgkin Lymphoma.

J Natl Compr Canc Netw. 2011 Sep 1;9(9):1020-58. No abstract available.

PMID:
21917626
26.

Technological advancements and error rates in radiation therapy delivery.

Margalit DN, Chen YH, Catalano PJ, Heckman K, Vivenzio T, Nissen K, Wolfsberger LD, Cormack RA, Mauch P, Ng AK.

Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4):e673-9. doi: 10.1016/j.ijrobp.2011.04.036. Epub 2011 Jun 12.

PMID:
21669503
27.

Cannabinoid receptor 2 and its agonists mediate hematopoiesis and hematopoietic stem and progenitor cell mobilization.

Jiang S, Alberich-Jorda M, Zagozdzon R, Parmar K, Fu Y, Mauch P, Banu N, Makriyannis A, Tenen DG, Avraham S, Groopman JE, Avraham HK.

Blood. 2011 Jan 20;117(3):827-38. doi: 10.1182/blood-2010-01-265082. Epub 2010 Nov 9. Retraction in: Blood. 2011 Aug 18;118(7):2027.

28.

Salvage radiotherapy in patients with recurrent or refractory primary or secondary central nervous system lymphoma after methotrexate-based chemotherapy.

Khimani NB, Ng AK, Chen YH, Catalano P, Silver B, Mauch PM.

Ann Oncol. 2011 Apr;22(4):979-84. doi: 10.1093/annonc/mdq548. Epub 2010 Oct 8.

PMID:
20935059
29.

Clinically significant cardiac disease in patients with Hodgkin lymphoma treated with mediastinal irradiation.

Galper SL, Yu JB, Mauch PM, Strasser JF, Silver B, Lacasce A, Marcus KJ, Stevenson MA, Chen MH, Ng AK.

Blood. 2011 Jan 13;117(2):412-8. doi: 10.1182/blood-2010-06-291328. Epub 2010 Sep 21.

PMID:
20858859
30.

Breastfeeding in survivors of Hodgkin lymphoma treated with chest radiotherapy.

McCullough L, Ng A, Najita J, Janov A, Henderson T, Mauch P, Diller L.

Cancer. 2010 Oct 15;116(20):4866-71. doi: 10.1002/cncr.25442.

31.

Sexual functioning in long-term survivors of Hodgkin's lymphoma.

Recklitis CJ, Sanchez Varela V, Ng A, Mauch P, Bober S.

Psychooncology. 2010 Nov;19(11):1229-33. doi: 10.1002/pon.1679.

PMID:
20035526
32.

Early-stage, lymphocyte-predominant Hodgkin's lymphoma: patient outcomes from a large, single-institution series with long follow-up.

Chen RC, Chin MS, Ng AK, Feng Y, Neuberg D, Silver B, Pinkus GS, Stevenson MA, Mauch PM.

J Clin Oncol. 2010 Jan 1;28(1):136-41. doi: 10.1200/JCO.2009.24.0945. Epub 2009 Nov 23.

PMID:
19933914
33.

What is the appropriate systemic chemotherapy for lymphocyte-predominant Hodgkin's lymphoma?

Canellos GP, Mauch P.

J Clin Oncol. 2010 Jan 1;28(1):e8. doi: 10.1200/JCO.2009.26.3293. Epub 2009 Nov 23. No abstract available.

PMID:
19933898
34.

Cost effectiveness and screening interval of lipid screening in Hodgkin's lymphoma survivors.

Chen AB, Punglia RS, Kuntz KM, Mauch PM, Ng AK.

J Clin Oncol. 2009 Nov 10;27(32):5383-9. doi: 10.1200/JCO.2009.22.8460. Epub 2009 Sep 14.

35.

Prognostic significance of mid- and post-ABVD PET imaging in Hodgkin's lymphoma: the importance of involved-field radiotherapy.

Sher DJ, Mauch PM, Van Den Abbeele A, LaCasce AS, Czerminski J, Ng AK.

Ann Oncol. 2009 Nov;20(11):1848-53. doi: 10.1093/annonc/mdp071. Epub 2009 Jun 18.

PMID:
19541793
36.

Late effects of Hodgkin's disease and its treatment.

Ng AK, Mauch PM.

Cancer J. 2009 Mar-Apr;15(2):164-8. doi: 10.1097/PPO.0b013e31819e30d7. Review.

PMID:
19390314
37.

A prospective study of salivary gland function in lymphoma patients receiving head and neck irradiation.

Rodrigues NA, Killion L, Hickey G, Silver B, Martin C, Stevenson MA, Mauch PM, Ng AK.

Int J Radiat Oncol Biol Phys. 2009 Nov 15;75(4):1079-83. doi: 10.1016/j.ijrobp.2008.12.053. Epub 2009 Mar 26.

PMID:
19327910
38.

Unilateral and bilateral breast cancer in women surviving pediatric Hodgkin's disease.

Basu SK, Schwartz C, Fisher SG, Hudson MM, Tarbell N, Muhs A, Marcus KJ, Mendenhall N, Mauch P, Kun LE, Constine LS.

Int J Radiat Oncol Biol Phys. 2008 Sep 1;72(1):34-40. doi: 10.1016/j.ijrobp.2008.04.068.

39.

Subsequent malignancies in children treated for Hodgkin's disease: associations with gender and radiation dose.

Constine LS, Tarbell N, Hudson MM, Schwartz C, Fisher SG, Muhs AG, Basu SK, Kun LE, Ng A, Mauch P, Sandhu A, Culakova E, Lyman G, Mendenhall N.

Int J Radiat Oncol Biol Phys. 2008 Sep 1;72(1):24-33. doi: 10.1016/j.ijrobp.2008.04.067.

40.

Response to low-dose involved-field radiotherapy in patients with non-Hodgkin's lymphoma.

Luthy SK, Ng AK, Silver B, Degnan KO, Fisher DC, Freedman AS, Mauch PM.

Ann Oncol. 2008 Dec;19(12):2043-7. doi: 10.1093/annonc/mdn529. Epub 2008 Jul 22.

41.

Hodgkin disease/lymphoma.

Hoppe RT, Advani RH, Ambinder RF, Bierman PJ, Bloomfield CD, Blum K, Dabaja B, Djulbegovic B, Forero A, Gordon LI, Hernandez-Ilizaliturri FJ, Hudson MM, Kaminski MS, Love G, Maloney DG, Mansur D, Mauch PM, Moore JO, Schilder RJ, Weiss LM, Winter JN, Yahalom J, Zelenetz AD; National Comprehensive Cancer Network.

J Natl Compr Canc Netw. 2008 Jul;6(6):594-622. No abstract available.

PMID:
18597713
42.

A prospective study of pulmonary function in Hodgkin's lymphoma patients.

Ng AK, Li S, Neuberg D, Chi R, Fisher DC, Silver B, Mauch PM.

Ann Oncol. 2008 Oct;19(10):1754-8. doi: 10.1093/annonc/mdn284. Epub 2008 May 7.

PMID:
18467315
43.

Stem-cell biology and cancer therapy: the more things change...

Hellman S, Botnick L, Mauch P.

J Clin Oncol. 2008 Feb 20;26(6):821-2. doi: 10.1200/JCO.2007.14.1416. No abstract available.

PMID:
18281648
44.

Health practice in long-term survivors of Hodgkin's lymphoma.

Ng AK, Li S, Recklitis C, Diller LR, Neuberg D, Silver B, Mauch PM.

Int J Radiat Oncol Biol Phys. 2008 Jun 1;71(2):468-76. doi: 10.1016/j.ijrobp.2007.09.028. Epub 2008 Jan 30.

PMID:
18234434
45.

Long-term survival after autologous bone marrow transplantation for follicular lymphoma in first remission.

Brown JR, Feng Y, Gribben JG, Neuberg D, Fisher DC, Mauch P, Nadler LM, Freedman AS.

Biol Blood Marrow Transplant. 2007 Sep;13(9):1057-65. Epub 2007 Jul 16.

46.

Nodular lymphocyte-predominant hodgkin lymphoma.

Tsai HK, Mauch PM.

Semin Radiat Oncol. 2007 Jul;17(3):184-9. Review.

PMID:
17591565
47.

Myeloablative therapy with autologous bone marrow transplantation for follicular lymphoma at the time of second or subsequent remission: long-term follow-up.

Rohatiner AZ, Nadler L, Davies AJ, Apostolidis J, Neuberg D, Matthews J, Gribben JG, Mauch PM, Lister TA, Freedman AS.

J Clin Oncol. 2007 Jun 20;25(18):2554-9. Epub 2007 May 21.

PMID:
17515573
48.

Distribution of hematopoietic stem cells in the bone marrow according to regional hypoxia.

Parmar K, Mauch P, Vergilio JA, Sackstein R, Down JD.

Proc Natl Acad Sci U S A. 2007 Mar 27;104(13):5431-6. Epub 2007 Mar 20.

49.

Role of radiation therapy in localized aggressive lymphoma.

Ng AK, Mauch PM.

J Clin Oncol. 2007 Mar 1;25(7):757-9. Epub 2007 Jan 16. No abstract available.

PMID:
17228015
50.

Role of radiation therapy in the treatment of stage I/II mucosa-associated lymphoid tissue lymphoma.

Tsai HK, Li S, Ng AK, Silver B, Stevenson MA, Mauch PM.

Ann Oncol. 2007 Apr;18(4):672-8. Epub 2007 Jan 11.

PMID:
17218489

Supplemental Content

Support Center